# Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia

> **NCT00003874** · PHASE1,PHASE2 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center**

## Conditions studied

- Leukemia
- Lymphoma

## Interventions

- **BIOLOGICAL:** monoclonal antibody CD19
- **BIOLOGICAL:** monoclonal antibody CD20
- **PROCEDURE:** in vitro-treated peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00003874
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-02
- **Primary completion:** —
- **Final completion:** 2001-09
- **Target enrollment:** — (—)
- **Last updated:** 2011-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003874, "Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00003874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*